Perspective Therapeutics Inc.
Perspective Therapeutics, Inc., together with its subsidiaries, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. The company discovers, and develop its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors tha… Read more
Perspective Therapeutics Inc. - Asset Resilience Ratio
Perspective Therapeutics Inc. (CATX) has an Asset Resilience Ratio of 49.99% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2007–2024)
This chart shows how Perspective Therapeutics Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Perspective Therapeutics Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $147.38 Million | 49.99% |
| Total Liquid Assets | $147.38 Million | 49.99% |
Asset Resilience Insights
- Very High Liquidity: Perspective Therapeutics Inc. maintains exceptional liquid asset reserves at 49.99% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Perspective Therapeutics Inc. Industry Peers by Asset Resilience Ratio
Compare Perspective Therapeutics Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
FluroTech Ltd
OTCQB:FLURF |
Medical Devices | 0.00% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Perspective Therapeutics Inc. (2007–2024)
The table below shows the annual Asset Resilience Ratio data for Perspective Therapeutics Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 48.47% | $165.34 Million | $341.10 Million | -- |
| 2023-12-31 | 0.00% | $0.00 | $97.89 Million | -- |
| 2023-06-30 | 39.19% | $22.76 Million | $58.09 Million | 0.00pp |
| 2022-12-31 | 39.19% | $22.76 Million | $58.09 Million | -- |
| 2022-06-30 | 0.00% | $0.00 | $64.44 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $64.44 Million | -- |
| 2021-06-30 | 0.00% | $0.00 | $70.42 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $15.51 Million | -- |
| 2019-06-30 | 0.00% | $0.00 | $9.42 Million | -- |
| 2018-12-31 | 8.76% | $825.00K | $9.42 Million | -2.31pp |
| 2018-06-30 | 11.07% | $825.00K | $7.46 Million | -13.70pp |
| 2017-12-31 | 24.77% | $3.04 Million | $12.27 Million | 0.00pp |
| 2017-06-30 | 24.77% | $3.04 Million | $12.27 Million | +12.36pp |
| 2016-12-31 | 12.41% | $2.25 Million | $18.10 Million | 0.00pp |
| 2016-06-30 | 12.41% | $2.25 Million | $18.10 Million | -28.29pp |
| 2015-12-31 | 40.70% | $9.36 Million | $23.00 Million | 0.00pp |
| 2015-06-30 | 40.70% | $9.36 Million | $23.00 Million | +3.02pp |
| 2014-12-31 | 37.68% | $10.00 Million | $26.55 Million | 0.00pp |
| 2014-06-30 | 37.68% | $10.00 Million | $26.55 Million | +23.37pp |
| 2009-12-31 | 14.31% | $1.68 Million | $11.74 Million | 0.00pp |
| 2009-06-30 | 14.31% | $1.68 Million | $11.74 Million | -6.61pp |
| 2008-12-31 | 20.92% | $3.73 Million | $17.81 Million | 0.00pp |
| 2008-06-30 | 20.92% | $3.73 Million | $17.81 Million | -17.21pp |
| 2007-12-31 | 38.13% | $9.94 Million | $26.08 Million | 0.00pp |
| 2007-06-30 | 38.13% | $9.94 Million | $26.08 Million | -- |